Header graphic for print
LimeGreenIP News

Tag Archives: FTC

Qualcomm Ordered to License the SEP Keys to its Modem Chip Kingdom

In a decision following a 10-day bench trial, Judge Lucy H. Koh ruled on May 21, 2019 in favor of plaintiff U.S. Federal Trade Commission (“FTC”) that defendant Qualcomm, Inc.’s (“Qualcomm’s”) licensing practices relating to its Standard Essential Patents (“SEPs”) violated both U.S. antitrust laws and Qualcomm’s contractual obligations to license its SEPs on fair,

Influencer promo guide: Best practices for drug and device firms

In our “Influencer promo guide: Best practices for drug and device firms”, we offered a list of best practices for medical device and pharmaceutical companies interested in taking advantage of the benefits of social media influencers for advertising their products, while adhering to FDA regulations. How can these companies be mindful of FDA rules while

FTC v. Qualcomm: Court Requires Licensing of SEPs to Competitors

A recent decision in the FTC v. Qualcomm Inc. case by U.S. district judge Lucy Koh calls into question the practice among some SEP holders of providing patent licenses only to downstream purchasers of products and refusing to provide licenses to direct competitors. In June 2017, the Federal Trade Commission (“FTC”) sued Qualcomm in the

US: How to avoid the FTC not “liking” your next campaign

The US Federal Trade Commission is clamping down on native advertising and the use of endorsements on social media. This article, first published in Managing IP, outlines a settlement which provides a number of lessons for brand owners. As advertisers are relying more heavily on social media platforms to create buzz around new products and services, a

U.S. – DOJ and FTC propose updated Antitrust Guidelines for Licensing of Intellectual Property

On August 12, the U.S. Department of Justice Antitrust Division (DOJ) and Federal Trade Commission (FTC) proposed updates to their Antitrust Guidelines for the Licensing of Intellectual Property (Guidelines). The agencies have not been amended the Guidelines since they were originally released in 1995. The revisions do not substantively modify the general principles of the